Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ephedra in Canada

This article was originally published in The Tan Sheet

Executive Summary

Health Canada warns consumers not to use products containing ephedra, either alone or in combination with caffeine and other stimulants, for weight loss, body building or increased energy in a June 14 advisory. Agency notes it authorizes ephedrine only for use as nasal decongestant in OTC cold products. Health Canada has been contemplating the advisory for some time, Nonprescription Drug Manufacturers Association of Canada says; agency's last action was about three years ago and addressed ma huang use in diet aids. Health Canada based recent advisory on review of FDA's AER database and 60 AERs, two of which were deaths, related to ephedra use in Canada before October 2000

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092709

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel